<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2026"
  xmlns:ck0002081119="http://www.robostrategy.com/20260716"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ck0002081119-20260716.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081119</identifier>
        </entity>
        <period>
            <startDate>2026-07-16</startDate>
            <endDate>2026-07-16</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081119</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">ck0002081119:RisksRelatedToTheListingOfOurSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-16</startDate>
            <endDate>2026-07-16</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-681">RoboStrategy, Inc.</dei:EntityRegistrantName>
    <cef:InvestmentObjectivesAndPracticesTextBlock contextRef="c0" id="ixv-356">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&lt;i&gt;The following is
added to the bullet point entitled &#x201c;Critical Infrastructure Companies&#x201d; in the &#x201c;Investment Strategy&#x201d; section of
the Prospectus summary and the &#x201c;Investment Objective&#x201d; subsection of the &#x201c;Investment Objective and Strategies&#x201d;
section of the Prospectus:&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;In addition to the quantitative
criteria described below, robotics or embodied AI adoption is a "meaningful driver" where the Adviser projects, at the time
of investment, that more than 50% of the company's future revenue growth will come from sales of the inputs described above into robotic
systems. The Adviser bases that projection on the company's revenues, backlog, purchase commitments and pipeline from robotics customers;
its research and development spending, capital expenditures and use of proceeds directed to robotics products; and the sensitivity of
its projected performance and valuation to the pace of robotics adoption.&lt;/p&gt;</cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:RiskFactorsTableTextBlock contextRef="c0" id="ixv-370">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;The following risk factors are added to the &#x201c;Types of Investments
and Related Risk Factors&#x201d; section of the Prospectus: &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Our Chairman and Chief Executive Officer
owns a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of August 4, 2026, Mr. Kang, our Chief Executive
Officer and Chairman, beneficially owns approximately 40.71% of shares of our issued and outstanding common stock. Therefore, Mr. Kang
has the ability to determine or significantly influence all matters requiring stockholder approval. For example, Mr. Kang may be able
to control or significantly influence the elections of directors, amendments to our organizational documents, or approval of any merger,
sale of assets, or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our
common stock that may be in your best interest as one of our stockholders.&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Risks Related to the Listing of Our Shares&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Our direct listing differed significantly
from listings arising from an underwritten initial public offering.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to the opening of trading of our shares
of common stock on the Exchange, there was no book-building process and no price at which underwriters initially sold shares to the public
to help inform efficient and sufficient price discovery with respect to the opening trades on the Exchange. The direct listing of our
shares of common stock on the Exchange differed from the listing of shares arising from an underwritten initial public offering in several
significant ways, which include, but are not limited to, the following:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="text-decoration:underline"&gt;There were no underwriters&lt;/span&gt;. Unlike in a traditional underwritten offering, our registration statement did not include the registration of additional shares that may be used at the option of the underwriters in connection with overallotment activity. Moreover, we did not engage in, and have not and will not, directly or indirectly, engage in any special selling efforts or stabilization or price support activities in connection with any sales made pursuant to this registration statement. In an underwritten initial public offering, the underwriters may engage in &#x201c;covered&#x201d; short sales in an amount of shares representing the underwriters&#x2019; option to purchase additional shares. To close a covered short position, the underwriters purchase shares in the open market or exercise the underwriters&#x2019; option to purchase additional shares. In determining the source of shares to close the covered short position, the underwriters typically consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the underwriters&#x2019; option to purchase additional shares. Purchases in the open market to cover short positions, as well as other purchases underwriters may undertake for their own accounts, may have the effect of preventing a decline in the trading price of shares of common stock following the underwritten offering. &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="text-decoration:underline"&gt;There was not a fixed or determined number of shares of common stock available for sale in connection with the registration and the listing of our shares of common stock&lt;/span&gt;. Therefore, there can be no assurance that the Selling Stockholders or other existing stockholders that may seek to sell their shares pursuant to Rule 144 of the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;) will sell any of their shares of common stock, and there may be a lack of supply of, or demand for, shares of our common stock on the Exchange. Alternatively, the Selling Stockholders or existing stockholders may choose to sell a large number of shares of common stock in the near term, resulting in potential oversupply of our common stock, which could adversely impact the trading price of our common stock.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="text-decoration:underline"&gt;We did not conduct a traditional &#x201c;roadshow&#x201d; with underwriters or host an &#x201c;investor day&#x201d; prior to the opening of trading of our common stock on the Exchange&lt;/span&gt;. Unlike firm commitment underwritten offerings, we did not conduct a traditional roadshow to potential investors, and unlike other direct listings of shares, we did not host an &#x201c;investor day&#x201d; or engage in investor education meetings that may have aided in determining the appropriate price at which our shares were initially offered on the Exchange. We instead relied on one or more designated market makers to determine the appropriate price at which our shares initially traded. &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Such differences from an underwritten initial
public offering may contribute to a volatile trading price for our common stock and uncertain trading volume, which may adversely affect
your ability to sell any shares of common stock that you may purchase.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;The public price of our shares of common
stock may have little or no relationship to the historical sales prices of our shares of common stock.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to listing on the Exchange, there was no
public market for our shares of common stock. With the exception of shares issued to initial seed investors in connection with the formation
of the Fund, all shares issued by the Fund were issued in a private offering pursuant to Regulation D under the Securities Act at a price
of $10.00 per share. The private offering price did not reflect, and should not be considered an indication of, the value of our common
stock or the price at which our common stock trades on the Exchange. Historical sale prices for our common stock, or our other securities,
may have little or no relation to the public price of our shares of common stock on the Exchange or to broader market demand for our shares
of common stock. As a result, you should not place undue reliance on these historical sales prices as they may differ materially from
the market prices at which our shares of common stock have traded and may trade in the future on the Exchange.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Direct listings by closed-end management
investment companies are infrequent, which could contribute to a volatile trading price and uncertain trading volume for our common stock.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We are organized as a non-diversified closed-end
management investment company that is registered under the 1940 Act. As discussed above, the direct listing of our shares of common stock
on the Exchange reflects a novel approach to the listing process, differs from the listing of shares arising from an underwritten initial
public offering in several significant ways, and subjects our investors to a number of significant risks and uncertainties. We believe
direct listings continue to be a relatively infrequent approach to listing securities on a national exchange, and that direct listings
by closed end management companies are conducted even less frequently. The low frequency of direct listings for closed-end management
companies indicates there may be limited opportunities for investors to compare an investment in our common stock to an investment in
another closed-end management company, which may limit interest in our common stock or create the perception that there is greater risk
associated with an investment in our common stock. This dynamic may exacerbate the risks associated with a direct listing, which could
result in greater volatility in the trading price for and uncertainty in the trading volume of our common stock.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Investors in our common stock may be unable
to bring claims under Sections 11 and 12(a)(2) of the Securities Act due to the requirement to trace shares to the applicable registration
statement, which may limit the remedies available to investors acquiring shares in a direct listing and adversely impact the market price
of our common stock.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In a traditional underwritten initial public offering,
investors can generally trace their shares to the registration statement, enabling them to bring claims under Sections 11 and 12(a)(2)
of the Securities Act for material misstatements or omissions. However, in a direct listing such as the one we undertook, which did not
involve a firm commitment underwriting, where both registered and unregistered shares may be sold into the public market on the first
day of trading, investors may be unable to establish that their shares were offered and sold pursuant to the registration statement. As
a result, liability under Section 11 (and potentially Section 12(a)(2)) may be unavailable to some investors, even in the event of a material
misstatement or omission in the registration statement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In June 2023, the U.S. Supreme Court held that
stockholders asserting Section 11 claims must plead and prove that their shares are traceable to the allegedly defective registration
statement. The U.S. Court of Appeals for the Ninth Circuit confirmed that the tracing requirement applies in the context of direct listings,
and that tracing shares to a registration statement is particularly difficult where registered and unregistered shares begin trading at
the same time. While the scope of Section 12(a)(2) liability remains unresolved, courts may impose similar traceability requirements to
these claims, which would limit liability under that section as well.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accordingly, if investors purchase our common
stock in the open market, they may not be able to assert claims under Section 11 (and potentially Section 12(a)(2)) of the Securities
Act for any material misstatements or omissions in this prospectus or the registration statement of which this prospectus forms a part.
Because our potential liability under the Securities Act may be reduced as compared to a traditional initial public offering, investors
may face greater risk in a direct listing with respect to inaccurate or incomplete disclosures. In addition to reducing the potential
remedies available to investors and limiting recovery in the event of a violation of the federal securities laws, these dynamics may adversely
impact the market price of our common stock.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Our stock price may be volatile, and could
decline significantly and rapidly.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The listing of our common stock and the registration
of the Selling Stockholders&#x2019; shares of common stock is a novel process that is not an underwritten initial public offering.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If the trading price of our common stock is above
the level that investors determine is reasonable for our common stock, some investors may attempt to short our common stock, which would
create additional downward pressure on the trading price of our common stock.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The trading price of our common stock also could
be subject to wide fluctuations in response to numerous factors in addition to the ones described in the preceding risk factors, many
of which are beyond our control, including:&lt;/p&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;actual or anticipated fluctuations in our financial condition, results of operations, or operating metrics
and those of our competitors;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the number of shares of our common stock made available for trading;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;failure of securities analysts to initiate or maintain coverage of us, changes in financial estimates
by any securities analysts who follow our company, or variance in our financial performance from expectations of securities analysts;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;changes in our projected operating and financial results;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;future sales of our common stock by us or our stockholders;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;changes in our Board, senior management, or key personnel;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the trading volume of our common stock;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;general economic and market conditions; and&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;other events or factors, including those resulting from war, incidents of terrorism, pandemics, elections,
or responses to these events.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;An active, liquid, and orderly market for
our common stock may not be sustained. You may be unable to sell your shares of common stock at or above the price at which you purchased
them.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to listing on the Exchange, there was no
public market for our common stock. Moreover, consistent with Regulation M and other federal securities laws applicable to our listing,
the Selling Stockholders have no specific plans to sell shares in the public market, and we have not discussed with potential investors
their intentions to buy our common stock in the open market. While our common stock may be sold on the Exchange by the Selling Stockholders
pursuant to this Prospectus or by our other existing stockholders in accordance with Rule 144 of the Securities Act, unlike an underwritten
initial public offering, there can be no assurance that the Selling Stockholders or other existing stockholders will sell any of their
shares of common stock, and there may be a lack of supply of, or demand for, common stock on the Exchange. Conversely, there can be no
assurance that the Selling Stockholders and other existing stockholders will not sell all of their shares of common stock, resulting in
an oversupply of our common stock on the Exchange. In the case of a lack of supply of our common stock, the trading price of our common
stock may rise to an unsustainable level. Further, institutional investors may be discouraged from purchasing our common stock if they
are unable to purchase a block of our common stock in the open market in a sufficient size for their investment objectives due to a potential
unwillingness of our existing stockholders to sell a sufficient amount of common stock at the price offered by such institutional investors
and the greater influence individual investors have in setting the trading price. If institutional investors are unable to purchase our
common stock in a sufficient amount for their investment objectives, the market for our common stock may be more volatile without the
influence of long-term institutional investors holding significant amounts of our common stock. In the case of a lack of demand for our
common stock, the trading price of our common stock could decline significantly and rapidly. Therefore, an active, liquid, and orderly
trading market for our common stock may not be sustained, which could significantly depress the trading price of our common stock and/or
result in significant volatility, which could affect your ability to sell your shares of common stock.&lt;/p&gt;</cef:RiskFactorsTableTextBlock>
    <cef:RiskTextBlock contextRef="c1" id="ixv-408">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Risks Related to the Listing of Our Shares&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Our direct listing differed significantly
from listings arising from an underwritten initial public offering.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to the opening of trading of our shares
of common stock on the Exchange, there was no book-building process and no price at which underwriters initially sold shares to the public
to help inform efficient and sufficient price discovery with respect to the opening trades on the Exchange. The direct listing of our
shares of common stock on the Exchange differed from the listing of shares arising from an underwritten initial public offering in several
significant ways, which include, but are not limited to, the following:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="text-decoration:underline"&gt;There were no underwriters&lt;/span&gt;. Unlike in a traditional underwritten offering, our registration statement did not include the registration of additional shares that may be used at the option of the underwriters in connection with overallotment activity. Moreover, we did not engage in, and have not and will not, directly or indirectly, engage in any special selling efforts or stabilization or price support activities in connection with any sales made pursuant to this registration statement. In an underwritten initial public offering, the underwriters may engage in &#x201c;covered&#x201d; short sales in an amount of shares representing the underwriters&#x2019; option to purchase additional shares. To close a covered short position, the underwriters purchase shares in the open market or exercise the underwriters&#x2019; option to purchase additional shares. In determining the source of shares to close the covered short position, the underwriters typically consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the underwriters&#x2019; option to purchase additional shares. Purchases in the open market to cover short positions, as well as other purchases underwriters may undertake for their own accounts, may have the effect of preventing a decline in the trading price of shares of common stock following the underwritten offering. &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="text-decoration:underline"&gt;There was not a fixed or determined number of shares of common stock available for sale in connection with the registration and the listing of our shares of common stock&lt;/span&gt;. Therefore, there can be no assurance that the Selling Stockholders or other existing stockholders that may seek to sell their shares pursuant to Rule 144 of the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;) will sell any of their shares of common stock, and there may be a lack of supply of, or demand for, shares of our common stock on the Exchange. Alternatively, the Selling Stockholders or existing stockholders may choose to sell a large number of shares of common stock in the near term, resulting in potential oversupply of our common stock, which could adversely impact the trading price of our common stock.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="text-decoration:underline"&gt;We did not conduct a traditional &#x201c;roadshow&#x201d; with underwriters or host an &#x201c;investor day&#x201d; prior to the opening of trading of our common stock on the Exchange&lt;/span&gt;. Unlike firm commitment underwritten offerings, we did not conduct a traditional roadshow to potential investors, and unlike other direct listings of shares, we did not host an &#x201c;investor day&#x201d; or engage in investor education meetings that may have aided in determining the appropriate price at which our shares were initially offered on the Exchange. We instead relied on one or more designated market makers to determine the appropriate price at which our shares initially traded. &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Such differences from an underwritten initial
public offering may contribute to a volatile trading price for our common stock and uncertain trading volume, which may adversely affect
your ability to sell any shares of common stock that you may purchase.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;The public price of our shares of common
stock may have little or no relationship to the historical sales prices of our shares of common stock.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to listing on the Exchange, there was no
public market for our shares of common stock. With the exception of shares issued to initial seed investors in connection with the formation
of the Fund, all shares issued by the Fund were issued in a private offering pursuant to Regulation D under the Securities Act at a price
of $10.00 per share. The private offering price did not reflect, and should not be considered an indication of, the value of our common
stock or the price at which our common stock trades on the Exchange. Historical sale prices for our common stock, or our other securities,
may have little or no relation to the public price of our shares of common stock on the Exchange or to broader market demand for our shares
of common stock. As a result, you should not place undue reliance on these historical sales prices as they may differ materially from
the market prices at which our shares of common stock have traded and may trade in the future on the Exchange.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Direct listings by closed-end management
investment companies are infrequent, which could contribute to a volatile trading price and uncertain trading volume for our common stock.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We are organized as a non-diversified closed-end
management investment company that is registered under the 1940 Act. As discussed above, the direct listing of our shares of common stock
on the Exchange reflects a novel approach to the listing process, differs from the listing of shares arising from an underwritten initial
public offering in several significant ways, and subjects our investors to a number of significant risks and uncertainties. We believe
direct listings continue to be a relatively infrequent approach to listing securities on a national exchange, and that direct listings
by closed end management companies are conducted even less frequently. The low frequency of direct listings for closed-end management
companies indicates there may be limited opportunities for investors to compare an investment in our common stock to an investment in
another closed-end management company, which may limit interest in our common stock or create the perception that there is greater risk
associated with an investment in our common stock. This dynamic may exacerbate the risks associated with a direct listing, which could
result in greater volatility in the trading price for and uncertainty in the trading volume of our common stock.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Investors in our common stock may be unable
to bring claims under Sections 11 and 12(a)(2) of the Securities Act due to the requirement to trace shares to the applicable registration
statement, which may limit the remedies available to investors acquiring shares in a direct listing and adversely impact the market price
of our common stock.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In a traditional underwritten initial public offering,
investors can generally trace their shares to the registration statement, enabling them to bring claims under Sections 11 and 12(a)(2)
of the Securities Act for material misstatements or omissions. However, in a direct listing such as the one we undertook, which did not
involve a firm commitment underwriting, where both registered and unregistered shares may be sold into the public market on the first
day of trading, investors may be unable to establish that their shares were offered and sold pursuant to the registration statement. As
a result, liability under Section 11 (and potentially Section 12(a)(2)) may be unavailable to some investors, even in the event of a material
misstatement or omission in the registration statement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In June 2023, the U.S. Supreme Court held that
stockholders asserting Section 11 claims must plead and prove that their shares are traceable to the allegedly defective registration
statement. The U.S. Court of Appeals for the Ninth Circuit confirmed that the tracing requirement applies in the context of direct listings,
and that tracing shares to a registration statement is particularly difficult where registered and unregistered shares begin trading at
the same time. While the scope of Section 12(a)(2) liability remains unresolved, courts may impose similar traceability requirements to
these claims, which would limit liability under that section as well.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accordingly, if investors purchase our common
stock in the open market, they may not be able to assert claims under Section 11 (and potentially Section 12(a)(2)) of the Securities
Act for any material misstatements or omissions in this prospectus or the registration statement of which this prospectus forms a part.
Because our potential liability under the Securities Act may be reduced as compared to a traditional initial public offering, investors
may face greater risk in a direct listing with respect to inaccurate or incomplete disclosures. In addition to reducing the potential
remedies available to investors and limiting recovery in the event of a violation of the federal securities laws, these dynamics may adversely
impact the market price of our common stock.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Our stock price may be volatile, and could
decline significantly and rapidly.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The listing of our common stock and the registration
of the Selling Stockholders&#x2019; shares of common stock is a novel process that is not an underwritten initial public offering.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If the trading price of our common stock is above
the level that investors determine is reasonable for our common stock, some investors may attempt to short our common stock, which would
create additional downward pressure on the trading price of our common stock.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The trading price of our common stock also could
be subject to wide fluctuations in response to numerous factors in addition to the ones described in the preceding risk factors, many
of which are beyond our control, including:&lt;/p&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;actual or anticipated fluctuations in our financial condition, results of operations, or operating metrics
and those of our competitors;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the number of shares of our common stock made available for trading;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;failure of securities analysts to initiate or maintain coverage of us, changes in financial estimates
by any securities analysts who follow our company, or variance in our financial performance from expectations of securities analysts;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;changes in our projected operating and financial results;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;future sales of our common stock by us or our stockholders;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;changes in our Board, senior management, or key personnel;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the trading volume of our common stock;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;general economic and market conditions; and&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;other events or factors, including those resulting from war, incidents of terrorism, pandemics, elections,
or responses to these events.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;An active, liquid, and orderly market for
our common stock may not be sustained. You may be unable to sell your shares of common stock at or above the price at which you purchased
them.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to listing on the Exchange, there was no
public market for our common stock. Moreover, consistent with Regulation M and other federal securities laws applicable to our listing,
the Selling Stockholders have no specific plans to sell shares in the public market, and we have not discussed with potential investors
their intentions to buy our common stock in the open market. While our common stock may be sold on the Exchange by the Selling Stockholders
pursuant to this Prospectus or by our other existing stockholders in accordance with Rule 144 of the Securities Act, unlike an underwritten
initial public offering, there can be no assurance that the Selling Stockholders or other existing stockholders will sell any of their
shares of common stock, and there may be a lack of supply of, or demand for, common stock on the Exchange. Conversely, there can be no
assurance that the Selling Stockholders and other existing stockholders will not sell all of their shares of common stock, resulting in
an oversupply of our common stock on the Exchange. In the case of a lack of supply of our common stock, the trading price of our common
stock may rise to an unsustainable level. Further, institutional investors may be discouraged from purchasing our common stock if they
are unable to purchase a block of our common stock in the open market in a sufficient size for their investment objectives due to a potential
unwillingness of our existing stockholders to sell a sufficient amount of common stock at the price offered by such institutional investors
and the greater influence individual investors have in setting the trading price. If institutional investors are unable to purchase our
common stock in a sufficient amount for their investment objectives, the market for our common stock may be more volatile without the
influence of long-term institutional investors holding significant amounts of our common stock. In the case of a lack of demand for our
common stock, the trading price of our common stock could decline significantly and rapidly. Therefore, an active, liquid, and orderly
trading market for our common stock may not be sustained, which could significantly depress the trading price of our common stock and/or
result in significant volatility, which could affect your ability to sell your shares of common stock.&lt;/p&gt;</cef:RiskTextBlock>
    <dei:DocumentType contextRef="c0" id="ixv-684">424B3</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-685">0002081119</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-686">false</dei:AmendmentFlag>
</xbrl>
